Corcept Therapeutics’ Post

View organization page for Corcept Therapeutics, graphic

34,803 followers

Today at ADA our CATALYST data are being presented in the session: ADA Catalyst Plenary - Prevalence of Hypercortisolism in Difficult to Control Type 2 Diabetes. We look forward to the insightful discussion, which will be held in W415B (Valencia Ballroom) from 3:15pm – 4:15pm EDT. American Diabetes Association #CortisolModulation #Diabetes #ADASciSessions #Hypercortisolism

  • No alternative text description for this image
Mike Petkov

Clinical Trial Manager

1mo

Looks interesting, is there a live stream?

Like
Reply

To view or add a comment, sign in

Explore topics